isavuconazole

Isavuconazole is a new generation triazol that has been using for the treatment of mucormycosis in the Russian Federation since 2021. A clinical case and results of a prospective multicenter study of the clinical features and results of mucormycosis …

The steadily increasing incidence of invasive fungal infections, influenced to some extent by the COVID-19 pandemic, caused by both yeast and molds makes it necessary to improve the antifungal therapies used. Historically, azoles have held a key …

Over the last decade, the introduction of new antifungal drugs and diagnostic procedures has improved the prognosis of hematological patients with invasive fungal disease (IFD), primarily invasive aspergillosis. Despite effective antifungal …